LeonaBio (LONA) EPS (Weighted Average and Diluted) (2021 - 2026)
LeonaBio (LONA) reported EPS (Weighted Average and Diluted) of -$1.73 for Q1 2026, up 26.07% year-over-year from -$1.37 in Q1 2025, and up 90.85% on a QoQ basis from -$18.9 in Q4 2025.
LeonaBio (LONA) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$1.73 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 26.07% year-over-year to -$1.73 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.49 (down 56.62% YoY) and the FY2025 annual result came in at -$24.7, up 1.95% from the prior year.
- EPS (Weighted Average and Diluted) climbed to -$1.73 in Q1 2026 per LONA's latest filing, from -$18.9 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.18 in Q2 2025 and bottomed at -$18.9 in Q4 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.78 (2023), against an average of -$2.54.
- The widest annual swing landed in 2024, when EPS (Weighted Average and Diluted) tumbled 757.47%; it then jumped 77.48% in 2025.
- Tracing LONA's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.79 in 2022, then advanced by 10.13% to -$0.71 in 2023, then tumbled by 443.66% to -$3.86 in 2024, then sank by 389.64% to -$18.9 in 2025, then soared by 90.85% to -$1.73 in 2026.
- Per Business Quant, the three latest LONA EPS (Weighted Average and Diluted) figures stand at -$1.73 (Q1 2026), -$18.9 (Q4 2025), and -$1.68 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.51 |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -1.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73 |
| Dec 31, 2025 | -18.90 |
| Sep 30, 2025 | -1.68 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -2.34 |
| Dec 31, 2024 | -3.86 |
| Sep 30, 2024 | -7.46 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.87 |
| Jun 30, 2023 | -0.78 |
| Mar 31, 2023 | -0.73 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -0.44 |
| Sep 30, 2021 | -0.42 |